FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

Urticaria Is Often a Team Sport for Derms and Allergists

Chronic urticaria is occasionally challenging, but dermatologists and allergists can help each other as well as the patient by combining their unique skills in difficult cases.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Lactate Dehydrogenase and Outcomes in HFrEF

Insights on the relationship between LDH and clinical outcomes from the GALACTIC-HF, a phase 3, randomized, placebo-controlled trial evaluating omecamtiv mecarbil in HFrEF.

The Only Sleep Study I Can Get Is a PAT

The in-home, patient-friendly peripheral arterial tonometry test seems to be the wave of the future for diagnosing obstructive sleep apnea. Dr Aaron Holley discusses this wearable device known as PAT.

US NIH Names John Powers III as Acting Director Of Infectious Disease Institute

The National Institutes of Health appointed Dr. John Powers III as ⁠acting director of its infectious disease institute, the agency's website showed on...

Drug-Induced Alopecia: When to Suspect and How to Treat It

Experts highlight clues that help identify drug-induced alopecia and outline treatment strategies tailored to the underlying mechanism and pattern of hair loss.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Latest News

Chronic urticaria is occasionally challenging, but dermatologists and allergists can help each other as well as the patient by combining their unique skills in difficult cases.

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Insights on the relationship between LDH and clinical outcomes from the GALACTIC-HF, a phase 3, randomized, placebo-controlled trial evaluating omecamtiv mecarbil in HFrEF.

The in-home, patient-friendly peripheral arterial tonometry test seems to be the wave of the future for diagnosing obstructive sleep apnea. Dr Aaron Holley discusses this wearable device known as PAT.

The National Institutes of Health appointed Dr. John Powers III as ⁠acting director of its infectious disease institute, the agency's website showed on...

Experts highlight clues that help identify drug-induced alopecia and outline treatment strategies tailored to the underlying mechanism and pattern of hair loss.

News All Time

CCL19 as a Biomarker May Track IgG4-Related Disease Activity

CCL19 emerges as a promising biomarker that distinguishes active disease from treatment-induced remission and may help to identify relapsing disease in patients with IgG4-related disease.

Race-Neutral Data Show Biologics’ Benefits for Kids’ Asthma

Lung function shows improvement using GLI global reference equations.

Visible Light and Skin Health: What Clinicians Should Know

An international expert panel issues consensus recommendations on visible light photoprotection, highlighting its emerging role in skin health and disease.

Several Markers May Flag Severity of Peanut Allergy in Kids

Several biomarker measures such as wheal diameters on skin prick tests, peanut-specific antibody levels, and basophil activation differ between children with severe vs mild reactions to peanuts.

MHRA Approves Nipocalimab for Myasthenia Gravis

The MHRA has authorised nipocalimab for generalised myasthenia gravis in adults and adolescents aged 12 and over, based on evidence from two clinical studies.

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Ontario Researchers Discover Promising Antibiotic

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

TNFi Use in Early Peripheral SpA Outperforms Methotrexate

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

Lyme Primer: How the HHS Strategy Stacks Up To Science

Experts support targeting ticks but caution against the long-term use of antibiotics.

FDA Approves First New Sunscreen Option in Two Decades

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

US Adds $38 Million for Ebola as CDC Warns Outbreak Could Match 2014

The United States said on Friday it would provide an additional $38 million for Ebola response efforts, as the CDC warned that without strong public health interventions the...

Whole Blood vs Components: No Survival Benefit in Trauma

Prehospital transfusion with whole blood was not linked to reduced 30-day mortality compared with prehospital transfusion with blood components in patients with traumatic hemorrhage, a phase 3 trial finds.

New POCUS for Residents: Should Hospitalists Join?

Few attending hospitalists have formal training in point-of-care ultrasound, but more are eager to learn.

Hospitalists Leading Health Informatics in the Digital Age

Technology in hospitals is changing quickly, having clinicians at the helm makes a difference.

Health Experts to Screen US Wastewater for Disease Outbreaks During World Cup

Epidemiologists will be busy this summer sifting through sewage and social media with the goal of keeping soccer fans and the public safe from severe illness during the...

Recommended News For You

Single-dose radiation before surgery can eradicate breast cancer

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

The September 2018 issue of Medical Bulletin.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

Recommended Articles For You

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies 

Clinical Methods in Hematology and Quality Improvement 

The Growing Challenge of Haematological Malignancies in Older Adults 

Tremelimumab: A Potential Breakthrough in Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A prostate cancer risk prediction algorithm could help target men at highest risk

2.

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

3.

Detecting pancreatic cancer through changes in body composition and metabolism

4.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

5.

New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations

1.

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions

2.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide 

3.

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis

4.

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology

5.

Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

2.

Current Scenario of Cancer- Q&A Session to Close the Gap

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

4.

Navigating the Complexities of Ph Negative ALL - Part XII

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot